首页> 外文期刊>Amino acids >Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications
【24h】

Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications

机译:单一和合并二甲双胍和L-瓜氨酸补充对Becker肌营养不良患者L-精氨酸相关途径的影响:可能的生化和临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

The L-arginine/nitric oxide synthase (NOS) pathway is considered to be altered in muscular dystrophy such as Becker muscular dystrophy (BMD). We investigated two pharmacological options aimed to increase nitric oxide (NO) synthesis in 20 male BMD patients (age range 21-44 years): (1) supplementation with L-citrulline (3 x 5 g/d), the precursor of L-arginine which is the substrate of neuronal NO synthase (nNOS); and (2) treatment with the antidiabetic drug metformin (3 x 500 mg/d) which activates nNOS in human skeletal muscle. We also investigated the combined use of L-citrulline (3 x 5 g/d) and metformin (3 x 500 mg/d). Before and after treatment, we measured in serum and urine samples the concentration of amino acids and metabolites of L-arginine-related pathways and the oxidative stress biomarker malondialdehyde (MDA). Compared to healthy subjects, BMD patients have altered NOS, arginine:glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT) pathways. Metformin treatment resulted in concentration decrease of arginine and MDA in serum, and of homoarginine (hArg) and guanidinoacetate (GAA) in serum and urine. L-Citrulline supplementation resulted in considerable increase of the concentrations of amino acids and creatinine in the serum, and in their urinary excretion rates. Combined use of metformin and L-citrulline attenuated the effects obtained from their single administrations. Metformin, L-citrulline or their combination did not alter serum nitrite and nitrate concentrations and their urinary excretion rates. In conclusion, metformin or L-citrulline supplementation to BMD patients results in remarkable antidromic changes of the AGAT and GAMT pathways. In combination, metformin and L-citrulline at the doses used in the present study seem to abolish the biochemical effects of the single drugs in slight favor of L-citrulline.
机译:L-精氨酸/一氧化氮合酶(NOS)途径被认为是在肌营养不良症的诸如Becker肌营养不良症(BMD)中的肌营养不良症。我们调查了旨在增加20名雄性BMD患者的一氧化氮(NO)合成的药理选择(21-44岁):(1)用L-瓜氨酸(3×5g / d)补充,L-的前体精氨酸,即神经元没有合酶(NNOS); (2)用抗糖尿病药物二甲双胍(3×500mg / d)治疗,其在人骨骼肌中激活NNOS。我们还研究了L-瓜氨酸(3×5g / d)和二甲双胍(3×500mg / d)的合并使用。在治疗之前和之后,我们在血清中测量,尿液样本氨基酸的浓度和L-精氨酸相关途径和氧化应激生物标志物丙二醛(MDA)的浓度。与健康受试者相比,BMD患者已改变NoS,精氨酸:甘氨酸酰胺转移酶(Agat)和胍基乙酸甲酯甲基转移酶(GAMT)途径。二甲双胍治疗导致血清中精氨酸和MDA的浓度降低,以及在血清和尿液中的Homoarginine(HARG)和胍基乙酸酯(Gaa)。 L-瓜氨酸补充导致血清中氨基酸和肌酐的浓度相当大,并在其尿液排泄率。联合使用二甲双胍和L-瓜氨酸抑制了从其单一主管署获得的效果。二甲双胍,L-瓜氨酸或其组合没有改变亚硝酸​​盐和硝酸盐浓度及其尿排泄率。总之,二甲双胍或L-瓜氨酸补充到BMD患者导致藿病和GAMT途径的显着抗抗原性变化。在本研究中使用的剂量的组合中,二甲双胍和L-瓜氨酸似乎取消了单一药物在L-瓜氨酸的轻微青睐中的生化作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号